The Nasdaq indicated that there was a record amount of biotech initial public offerings (IPOs) in 2018, totaling around $8.2 billion raised, breaking 2014’s record of $6.5 billion.

The U.S. FDA approved the New Drug Application for Nicox S.A.’s Zerviate, the first topical ocular formulation of the well-known antihistamine cetirizine.